Blockchain Registration Transaction Record

Telomir Pharmaceuticals' Telomir-1 Shows Promise in Reversing Macular Degeneration in Preclinical Study

Telomir Pharmaceuticals announces positive preclinical results for Telomir-1 in reversing retinal degeneration in zebrafish model of AMD. Learn how this breakthrough could lead to regenerative treatments for macular degeneration.

Telomir Pharmaceuticals' Telomir-1 Shows Promise in Reversing Macular Degeneration in Preclinical Study

This news matters as Telomir Pharmaceuticals' breakthrough in reversing retinal degeneration in a zebrafish model of AMD could lead to potential regenerative treatments for age-related macular degeneration, offering hope for improved vision and quality of life for patients.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x6cd41af6f749339fb91ff2ddf57bcbff9c92a0ef2ba27e9dc1fcb2d54becd75b
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintloss5u72-52e940c6baadff8b752c75301781b00b